Real-time enrollment status for this myelodysplastic syndromes clinical trial
Current Status
Recruiting
Checked: August 28, 2026 at 6:00 AM UTC
| NCT Number | NCT04245397 |
| Recruiting Status | Recruiting |
| Condition | Myelodysplastic Syndromes |
| Phase | PHASE1 |
| Target Enrollment | 151 participants |
| Active Locations | 7 sites in the US |
| Sponsor | Syntrix Biosystems, Inc. |
| Last Updated on CT.gov | December 23, 2025 (Dec 23, 2025) |
As of August 28, 2026: Clinical trial NCT04245397 is currently recruiting participants. This phase1 study for myelodysplastic syndromes is actively seeking new participants at 7 locations across the United States. The study is sponsored by Syntrix Biosystems, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT04245397 is actively recruiting participants as of August 28, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 7 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT04245397 was last updated Dec 23, 2025 (December 23, 2025). HelloStudys verifies this status automatically.